Impact of Roux-en-Y gastric bypass on regulation of diabetes type 2 in morbidly obese patients

Surgical Endoscopy

Volumn 26, Issue 8, 2012, Pages 2202-2207

  Proczko Markuszewska, Monika ^a   Stefaniak, Tomasz ^a   Kaska, Łukasz ^a   Kobiela, Jarek ^a   Śledziński, Zbigniew ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Diabetes mellitus type 2; Incretins; Metabolic surgery; Roux en Y gastric bypass

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; ROUX Y ANASTOMOSIS; STOMACH BYPASS; TREATMENT RESPONSE;

EID: 84864049548     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-012-2160-4     Document Type: Article

References (32)

1. King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995-2005: prevalence, numerical estimates, and projections. Diabetes Care 21:1414-1431
2. World Health Organization (2011) Health experts accept use of HbA1c for diagnosing diabetes. Geneva: WHO Diabetes Unit. Available at www.who.int/diabetes
3. International Diabetes Federation (2009) Diabetes Atlas, 4th edn. International Diabetes Federation, Brussels, Belgium
4. Patriti A, Facchiano E, Sanna A, Gullà N, MD, Aisa MC, Annetti C (2004) The enteroinsular axis and the recovery from type 2 diabetes after bariatric surgery. Obes Surg 14:840-848
5. Rubino F, Marescaux J (2004) Effect of duodenal-jejunal exclusion in non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg 239(1):1-11
6. Rubino F, Kaplan LM, Schauer PR, Cummings D on behalf of the Diabetes Surgery Summit Delegates (2010) The Diabetes Surgery Summit Consensus Conference. Recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg 251:399-405
7. Rubino F (2008) Is type 2 diabetes an operable intestinal disease? Diabetes Care 31(Suppl 2):S290-S296
8. Which surgical procedure should be carried out for type 2 diabetes. Presented at the IXth Meeting of the Surgical Continuing Education and XIVth Nutrition, University of Malaga, Malaga, 17-19 February 2010
9. 2nd World Congress on Interventional Therapies for Type 2 Diabetes, New York, 28-30 March, 2011. Available at www.wcidt.org
10. Bose M, Oliván B, Teixeira J, Pi-Sunyer FX, Laferrère B (2009) Do incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: what are the evidence? Obes Surg 19(2):217-229
11. Rubino F, Forgione A, Cummings DE, Vix M, Gnuli D, Mingione G, Castagneto M, Marescaux J (2006) The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 244(5):741-749
12. National Diabetes Information Clearinghouse (2008) Diagnosis of Diabetes. US Department of Health and Human Services, NIH Publication No. 09-4642
13. American Diabetes Association (2009) Diagnosis and classification of diabetes mellitus. Diabetes Care 32(1):S62-S66
14. Gautier JF, Fetita S, Sobngwi E, Salaun-Martin C (2005) Biological actions of incretins GIP and GIP-1 and therapeutic perspectives in patients with type 2 diabetes. Diabetes Metab 31:233-242
15. Mingrone G, Castagneto-Gissey L (2009) Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery. Diabetes Metab 35(6):518-523
16. Rubino F, Gagner M, Gentileschi P, Kini S, Fukuyama S, Feng J, Diamond E (2004) The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg 240(2):236-242
17. Rubino F, Schauer PR, Kaplan LM, Cummings DE (2010) Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med 61:393-411
18. Laferrere B (2009) Effect of gastric bypass surgery on the incretins. Diabetes Metab 35(6 Pt 2):513-517
19. Batsis JA, Sarr MG, Collazo-Clavell ML, Thomas RJ, Romero-Corral A, Somers VK, Lopez-Jimenez F (2008) Cardiovascular risk after bariatric surgery for obesity. Am J Cardiol 102(7):930-937
20. Christou NV, Lieberman M, Sampalis F, Sampalis JS (2008) Bariatric surgery reduces cancer risk in morbidly obese patients. Surg Obes Relat Dis 4(6):691-695
21. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122(3):248-256
22. Rubino F, R'bibo SL, del Genio F, Mazumdar M, McGraw TE (2010) Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus. Rev Endocrinol 6(2):102-109
23. Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C, Dahlgren S, Gummesson A, Jacobson P, Karlsson J, Lindroos AK, Lönroth H, Näslund I, Olbers T, Stenlöf K, Torgerson J, Ågren G, Carlsson A (2007) Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357:741-752
24. Kashyap SR, Bhatt DL, Schauer PR, STAMPEDE Investigators (2010) Bariatric surgery vs. advanced practice medical management in the treatment of type 2 diabetes mellitus: rationale and design of the Surgical Therapy And Medications Potentially Eradicate Diabetes Efficiently trial (STAMPEDE). Diabetes Obes Metab 12:452-454
25. Schauer PR, Burguera B, Ikramudin S, Cottam D, Gourash W, Hamad G, Eid GM, Mattar S, Ramanathan R, Barinas-Mitchel E, Rao H, Kuller L, Kelly D (2003) Effect of laparoscopic Roux-en-Y gastric bypass on type 2 diabetesmellitus. Ann Surg 238(4):467-485
26. Maitreyi R, Allard J (2006) Nonalcoholic fatty liver disease: a clinical approach and review. Can J Gastroenterol 20(5):345-349
27. Geloneze B, Geloneze SR, Fiori C, Stabe C, Tambascia MA, Chaim EA, Astiarraga BD, Pareja JC (2009) Surgery for nonobese type 2 patients: an interventional study with duodenaljejunal exclusion. Obes Surg 19(8):1077-1083
28. 2: an integrative review of early studies. Obes Surg 20(6):776-790
29. Dallegrave Marchesini JC (2007) End-to-side duodeno-jejunostomy with half-and-half biliopancreatic limb for the treatment of type 2 diabetes: a proposal for a simpler technique. Obes Surg 17(1):138-139
30. Prachand VN, Ward M, Alverdy JC (2010) Duodenal switch provides superior resolution of metabolic comorbidities independent of weight loss in the super-obese (BMI C 50 kg/m2) compared with gastric bypass. J Gastrointest Surg 14(2):211-220
31. Pories WJ, Swanson MS, MacDonald KG (1995) Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 222:339-350
32. Hussain A, Mahmood H, El-Hasani S (2009) Can Roux-en-Y gastric bypass provide a lifelong solution for diabetes mellitus? Can J Surg 52(6):E269-E275